JenniferLeighMcQuadeMD

Oncology • Houston, TX

Physician

Join to view full profile

Dr. McQuade is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. McQuade's full profile

Already have an account?

Office
1515 Holcombe Blvd
Houston, TX 77030
Phone+1 713-792-6161

Fax+1 713-745-7296

Education & Training

University of Pennsylvania Health SystemResidency, Internal Medicine, 2009 - 2012
Baylor College of MedicineClass of 2009

Certifications & Licensure

FL State Medical License 2021 - Present
TX State Medical License 2013 - 2026
OK State Medical License 2020 - 2021
NC State Medical License 2012 - 2014
PA State Medical License 2009 - 2012

Clinical Trials

Dietary Intervention in Patients With a History of Melanoma Start of enrollment: 2019 Apr 16
Recruiting
Phase 1
Effect of Diet on the Immune System in Patients With Stage III-IV Melanoma Receiving Immunotherapy, DIET Study Start of enrollment: 2020 Jun 24
Recruiting
Phase 2
Quality of Life, Lifestyle, and Psychosocial Factors in Patients With Melanoma Start of enrollment: 2015 Aug 26
Recruiting
Roles: Principal Investigator, Contact

Publications & Presentations

PubMed

Systematic Review and Meta-analysis of Acupuncture for Modulation of Immune and Inflammatory Markers in Cancer Patients.
Wenli Liu, Baisong Zhong, Richard W Wagner, M Kay Garcia, Jennifer L McQuade
Integrative Cancer Therapies. 2024-12-12
Diet and Immune Effects Trial (DIET)- a randomized, double-blinded dietary intervention study in patients with melanoma receiving immunotherapy.
Rachel M Farias, Yan Jiang, Erma J Levy, Cindy Hwang, Jian Wang
BMC Cancer. 2024-12-04
Body composition in recurrent prostate cancer and the role of steroidogenic genotype.
Neha Venkatesh, Rebecca S Tidwell, Yao Yu, Ana Aparicio, Amado J Zurita
Endocrine-Related Cancer. 2024-12-01

Lectures

Association of body mass index (BMI) with overall survival (OS) in metastatic melanoma (MM) patients (pts) treated with combined anti-CTLA4 + anti-PD1.
2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

Press Mentions

Obesity Linked to Higher Risk for Adverse Events from NivolumabDecember 8th, 2022
Eating Fiber Alters the Microbiome. It May Boost Cancer Treatment, TooNovember 8th, 2022
More Fiber for the Microbiome Could Boost Cancer Drugs for ImmunotherapyNovember 8th, 2022
Join now to see all